The Use of Autologous Mesenchymal Stem Cells for Cell Therapy of Patients with Amyotrophic Lateral Sclerosis in Belarus
- PMID: 26395626
- DOI: 10.1007/s10517-015-3017-3
The Use of Autologous Mesenchymal Stem Cells for Cell Therapy of Patients with Amyotrophic Lateral Sclerosis in Belarus
Abstract
We studied a new method of treatment of amyotrophic lateral sclerosis with autologous mesenchymal stem cells. Autologous mesenchymal stem cells were injected intravenously (intact cells) or via lumbar puncture (cells committed to neuronal differentiation). Evaluation of the results of cell therapy after 12-month follow-up revealed slowing down of the disease progression in 10 patients in comparison with the control group consisting of 15 patients. The cell therapy was safe for the patients.
Keywords: ALSFRS-R; Karnofsky scale; amyotrophic lateral sclerosis; autologous mesenchymal stem cells; neurogenic differentiation.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
